Search results
Results from the WOW.Com Content Network
But in people with dementia—which is an umbrella term for mental decline and can be related to a number of diseases such as Alzheimer's—there’s a phenomenon known as “sundowning,” where ...
To determine mental health problems, people usually use charting with papers, interviews, or smartphone to track their mood/affect/emotion. [3] [4] Furthermore, mood swings do not just fluctuate between mania and depression, but in some conditions, involve anxiety. [5] [6]
People showing signs of psychomotor agitation may be experiencing mental tension and anxiety, which comes out physically as: fast or repetitive movements; movements that have no purpose; movements that are not intentional; These activities are the subconscious mind's way of trying to relieve tension [citation needed]. Often people experiencing ...
Don’t forget to adjust your clocks, because the time will change on Sunday, Nov. 5 at 2 a.m. local time.
A survey by AARP in 2010 states that "29% of the U.S. adult population, or 65.7 million people, are caregivers, including 31% of all households. These caregivers provide an average of 20 hours of care per week." [7] 1.4 million children ages 8 to 18 provide care for an adult relative; 72% are caring for a parent or grandparent.
Elderly people often experience multiple comorbidities that may contribute to the phenomenon of sundowning syndrome through neurodegeneration. Neurological disorders: Alzheimer's disease, Parkinson's disease , Huntington's disease , Lewy body dementia , fronto-temporal dementia, subcortical dementia.
Frailty can have impacts on public health due to the factors that comprise the syndrome affecting physical and mental health outcomes. There are several ways to identify, prevent, and mitigate the prevalence of frailty and the evaluation of frailty can be done through clinical assessments created to combine recognized signs and symptoms of frailty.
The mini–mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. [1] [2] It is commonly used in medicine and allied health to screen for dementia. It is also used to estimate the severity and progression of cognitive impairment and ...